RxSight Overview
RxSight Target Price
Analysts' 12-month price predictions for RXST.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.31
Average Target Price
$11.00
107.2% upside
107.2% upside3 analysts in the last 4 months
High: $13 | Low: $9
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-07 | Needham | $11 | 107.2% upside |  |
| 2026-03-09 | Stifel NicolausThomas Stephan | $9 | 69.5% upside | |
| 2026-02-26 | NeedhamDavid Saxon | $13 | 144.8% upside | |
| 2026-01-20 | Piper Sandler | $11 | 107.2% upside | |
| 2025-12-02 | Morgan Stanley | $10 | 88.3% upside | |
| 2025-11-06 | Stifel Nicolaus | $10 | 88.3% upside | |
| 2024-10-29 | Mizuho SecuritiesAnthony Crowdell | $67 | 1161.8% upside | |
| 2024-10-29 | GuggenheimCurry Baker | $52 | 879.3% upside | |
| 2024-10-29 | BarclaysAdam Seiden | $110 | 1971.6% upside | |
| 2024-10-29 | JefferiesYoung Li | $72 | 1255.9% upside | |
| 2024-09-23 | BTIGRyan Zimmerman | $59 | 1011.1% upside | |
| 2024-09-13 | NeedhamDavid Saxon | $66 | 1142.9% upside | |
| 2024-08-06 | Stifel NicolausThomas Stephan | $65 | 1124.1% upside | |
| 2024-08-06 | NeedhamDavid Saxon | $54 | 916.9% upside | |
| 2024-05-07 | OppenheimerSteven Lichtman | $72 | 1255.9% upside | |
| 2024-05-07 | NeedhamDavid Saxon | $75 | 1312.4% upside | |
| 2024-05-07 | Stifel NicolausTom Stephan | $75 | 1312.4% upside | |
| 2024-05-07 | Wells FargoLawrence Biegelsen | $68 | 1180.6% upside | |
| 2024-05-07 | BTIGRyan Zimmerman | $72 | 1255.9% upside | |
| 2024-05-06 | Stifel NicolausThomas Stephan | $68 | 1180.6% upside | |
| 2023-12-13 | Wells FargoLawrence Biegelsen | $42 | 691% upside | |
| 2023-07-12 | NeedhamDavid Saxon | $34 | 540.3% upside | |